Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-11-17 | Michael Castagna, Pharm.D.(4) 57,837 * Includes 2,744 shares which Dr. Castagna has the right to acquire within 60 days of October 30, 2017 pursuant to the exercise of outstanding options. |
Data sourced from SEC filings. Last updated: 2025-10-12